Skip to search formSkip to main contentSkip to account menu

serogroup C meningococcal conjugate vaccine

Known as: meningococcal type C conjugate vaccine, meningococcal C conjugate vaccine, meningococcal C conjugate 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Meningococcal vaccine

Narrower (1)

Mnc-CRM197

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
Meningococcal Disease: Epidemiology and Early Effects of Immunization Programs.
Meningococcal disease (MD) is a major public health problem and remains an important cause of meningitis and sepsis in several… 
Highly Cited
2012
Highly Cited
2012
Safety and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers Given With Routine Pediatric Vaccinations in Canada
Background: The global distribution of pneumococcal disease and emergence of nonvaccine pneumococcal serotypes prompted the… 
2012
2012
Immunogenicity of a Single Dose of Meningococcal Group C Conjugate Vaccine Given at 3 Months of Age to Healthy Infants in the United Kingdom
Background: From 1999, in the United Kingdom, meningococcal C conjugate (MCC) vaccines from 3 manufacturers were introduced to… 
Review
2007
Review
2007
Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines.
At the end of 2005, six European countries had implemented public immunization campaigns with serogroup C conjugate vaccines, and… 
2007
2007
No increased risk of relapse after meningococcal C conjugate vaccine in nephrotic syndrome
Objectives: To investigate whether meningococcal C conjugate vaccine (MCCV) caused relapse in children with steroid-responsive… 
2005
2005
Immunogenicity and Immunologic Memory of Meningococcal C Conjugate Vaccine in Premature Infants
Background: Protein-polysaccharide conjugate vaccines against Neisseria meningitidis serogroup C were introduced into the U.K… 
Highly Cited
2003
Highly Cited
2003
Immunogenicity of, and Immunologic Memory to, a Reduced Primary Schedule of Meningococcal C-Tetanus Toxoid Conjugate Vaccine in Infants in the United Kingdom
ABSTRACT It has been previously shown that one of the three meningococcal C conjugate (MCC) vaccines introduced in the United… 
Highly Cited
2003
Highly Cited
2003
Risk of relapse after meningococcal C conjugate vaccine in nephrotic syndrome
2002
2002
Safety and immunogenicity of meningococcus serogroup C conjugate vaccine administered as a primary or booster vaccination to healthy four-year-old children
Background. Meningococcal C conjugate (Men C) vaccines have been routinely used in the UK since November, 1999. Little… 
Highly Cited
2001
Highly Cited
2001
Influence of prior meningococcal C polysaccharide vaccination on the response and generation of memory after meningococcal C conjugate vaccination in young children.
To determine whether the immunological hyporesponsiveness induced by meningococcal AC polysaccharide (MACP) vaccines can be… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)